Trevi Therapeutics (TRVI) Preferred Dividend Payments (2018 - 2019)

Trevi Therapeutics (TRVI) recorded quarterly Preferred Dividend Payments of $3.8 million in Q4 2019, up 200.0% quarter-over-quarter from -$3.8 million in Q3 2019, and down 33.51% on a YoY basis from $5.7 million in Q4 2018.

Trevi Therapeutics (TRVI) Preferred Dividend Payments (2018 - 2019) Analysis & Trends

Trevi Therapeutics' Preferred Dividend Payments history runs 2 years deep, the most recent figure standing at $3.8 million for Q4 2019.

  • In Q4 2019, Preferred Dividend Payments fell 33.51% year-over-year to $3.8 million; the TTM figure through Dec 2019 stood at -$1.5 million (down 128.42% YoY), while the FY2019 annual figure was $2.2 million, down 58.55% from the prior year.
  • Preferred Dividend Payments was $3.8 million for Q4 2019 at Trevi Therapeutics, up from -$3.8 million in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $5.7 million in Q4 2018 to a low of -$3.8 million in Q3 2019.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -
9 Abivax 91.96 Bn 91.96 Bn - -
10 Trevi Therapeutics 2.50 Bn 2.33 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2019 3.77 Mn
Sep 30, 2019 -3.77 Mn
Jun 30, 2019 -1.33 Mn
Mar 31, 2019 -203,000.00
Dec 31, 2018 5.68 Mn
Sep 30, 2018 96,000.00
Jun 30, 2018 -175,000.00
Mar 31, 2018 -195,000.00